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K M -co n o to x in  R II IK  b lo c k s  T S h a l  K + c h a n n e l s  f ro m  
t r o u t  w i th  h ig h  a f f in i t y  b y  i n t e r a c t i n g  w i th  t h e  io n  
c h a n n e l  p o r e .  A s o p p o s e d  to  m a n y  o t h e r  p e p t i d e s  t a r ­
g e t i n g  K + c h a n n e l s ,  k M -R IIIK  d o e s  n o t  p o s s e s s  a  f u n c ­
t i o n a l  d y a d .  I n  t h i s  s t u d y  w e  c o m b in e  th e r m o d y n a m ic  
m u t a n t  c y c le  a n a ly s i s  a n d  d o c k in g  c a lc u la t i o n s  to  d e ­
r iv e  th e  b in d i n g  m o d e  o f  K M -co n o to x in  R II IK  to  th e  
T S h a l  c h a n n e l .  T h e  f i n a l  m o d e l  r e v e a l s  a  n o v e l  p h a r ­
m a c o p h o r e ,  w h e r e  n o  p o s i t iv e ly  c h a r g e d  s id e  c h a in  
o c c lu d e s  t h e  c h a n n e l  p o r e .  I n s t e a d  th e  p o s i t iv e -  
c h a r g e d  r e s id u e s  o f  t h e  to x in  fo r m  a  b a s i c  r i n g ;  kM- 
R II IK  is  a n c h o r e d  to  th e  K + c h a n n e l  v ia  e l e c t r o s t a t i c  
in t e r a c t i o n s  o f  t h i s  b a s i c  r i n g  w i th  t h e  lo o p  a n d  p o r e  
h e l ix  r e s id u e s  o f  t h e  c h a n n e l .  T h e  c h a n n e l  a m in o  a c id  
G lu -3 5 4  is  l ik e ly  to  b e  a  f u n d a m e n ta l  d e t e r m i n a n t  o f  
th e  s e l e c t i v i t y  o f  k M -R IIIK  f o r  t h e  T S h a l  c h a n n e l .  T h e  
C y -O H  o f  H y p -1 5  i s  in  c o n ta c t  w i th  th e  c a r b o n y l s  o f  th e  
s e l e c t i v i t y  f i l t e r ,  d i s t u r b i n g  th e  c h a r g e  d i s t r i b u t i o n  
p a t t e r n  n e c e s s a r y  f o r  t h e  c o o r d i n a t i o n  o f  K + io n s . T h is  
n o v e l ,  e x p e r im e n ta l l y  b a s e d  p h a r m a c o p h o r e  m o d e l  
p r o v e s  t h e  e x is te n c e  o f  d iv e r s e  b in d i n g  m o d e s  o f  p e p -  
t i d ic  to x in s  to  K + c h a n n e l s  a n d  u n d e r l i n e s  t h e  r o l e  o f  
in t e r m o le c u l a r  e l e c t r o s t a t i c  i n t e r a c t i o n s  in v o lv in g  
c h a n n e l  lo o p  s id e  c h a in s  in  d e t e r m i n in g  th e  s e l e c t i v i ty  
o f  to x in s  f o r  s p e c i f ic  K + c h a n n e l  ty p e s .
Potassium (K ") channels are a very diverse group of proteins 
that are key elements for a variety of different physiological 
functions including the electrical excitability of cells (1). During 
evolution a great variability of peptide toxins targeting differ­
ent K" channels have been evolved by several venomous or­
ganisms including snakes, spiders, and scorpions. The venoms 
of the marine cone snails are known to contain different fami­
lies of peptides, the so-called conotoxins, which target ligand- 
gated and voltage-gated ion channels with great specificity. 
Meanwhile several conotoxins have been identified that have 
been shown to interact with voltage-activated K" channels. 
This includes the K-conotoxins and the xM-conotoxins (2).
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Recently the structure of KM-conotoxin R IIIK  (kM-RIIIK),1 a 
peptide obtained from a venom duct library from Conus radia­
tus, was solved by NMR analysis (3). kM-RIIIK is known to 
block Shaker and mammalian Kvl.2 K " channels, whereas the 
highest affinity target so far identified is TShal, a Shaker- 
related K" channel from trout (4, 5). Despite the entirely dif­
ferent pharmacological specificity, a high structural similarity 
has been observed between this peptide and /u-conotoxin GIIIA, 
which specifically blocks N a " channels, or i|/-conotoxin PIIIE, 
which is a non-competitive blocker of nicotinic acetylcholine 
receptors.
Structurally and phylogenetically unrelated toxins that in­
teract with voltage-activated K " channels usually share a dyad 
motif composed of a lysine and a hydrophobic amino acid res­
idue (Tyr or Phe). In particular, there is evidence that the 
lysine residue of this functional dyad occludes the K" channel 
pore (6- 8). This dyad has been proposed to be the minimal core 
domain of the K" channel binding pharmacophore (9-12). A 
systematic mutational analysis conducted for all non-cysteine 
residues of kM-RIIIK showed that kM-RIIIK does not contain a 
functional dyad (3), in contrast to most K" channel-targeting 
peptidic neurotoxins. In kM-RIIIK all the residues that are 
most relevant for function contain a positive charge; these 
residues define a basic ring separating two peptide surfaces. 
The peptide residues that are moderately relevant for binding 
cluster on one of the two surfaces, whereas those that are 
irrelevant for binding occupy the other surface. Based on the 
lack of the dyad and on the observation that all the functionally 
relevant residues are clustered on one surface of the peptide 
delimited by a ring of positive charges, a novel pharmacophore 
model was hypothesized for the kM-RIIIK-TShal complex. In 
this model the ring of positive charges is used as an anchor to 
residues of the K" channel loops, and kM-RIIIK blocks the 
channel by covering the pore as a lid (3). Additionally, no 
positively charged side chain penetrates the channel pore. The 
importance of a ring of basic residues for potassium channel 
binding was also proposed for the scorpion toxin P il by Mouhat 
et al. (13), indicating that a similar pharmacophore might have 
independently evolved for cone snails and scorpions.
In this study we investigate the interaction of kM-RIIIK with 
the pore of the TSha l  K" channel. We use the data from an 
extensive mutant cycle analysis to calculate the orientation of 
the peptide within the pore of the TShal channel, whose struc­
ture was derived by homology to the known KcsA structure 
(14). Previous work (7, 15) has demonstrated the validity of a
1 The abbreviations used are: kM-RIIIK, KM-conotoxin RIIIK; WT, 
wild type; r.s.m.d., root mean square deviation; O, Hyp.

























computational approach based on intermolecular distance re­
straints, which can be derived by mutant cycle data, for obtain­
ing models of the atomic interactions in bimolecular complexes. 
In this study the solution structure of kM-RIIIK is docked to 
the TS}ml channel, allowing full flexibility of the side chains of 
both the peptide and the protein and using 17 intermolecular 
distance restraints derived from experimental mutant cycle 
data. The resulting model for the kM-RIIIK-TShal complex 
indicates that kM-RIIIK indeed occludes the permeation path­
way as a lid, which is anchored by the electrostatic interaction 
of a ring of basic residues on the peptide surface with the outer 
vestibule of the ion channel pore. All functionally relevant 
residues belong to the interaction surface with the channel, 
whereas functionally irrelevant side chains are mostly pro­
jected toward solution. Specific electrostatic interactions be­
tween the positively charged side chains of the toxin and chan­
nel residues of the loop and outer helix regions are likely to be 
responsible for the selectivity of kM-RIIIK for the TShal chan­
nel. Furthermore, our model suggests that the trans-hy- 
droxyproline 15 of kM-RIIIK, which is the homologous residue 
of Arg-13 of ju-conotoxins GIIIA, interacts with the carbonyl 
groups within the selectivity filter of the channel, thereby 
occupying the permeation pathway. Arg-13 of /u-conotoxins has 
been demonstrated to be essential for blocking the pore of Na h 
channels (2, 16, 17). Our finding indicates that pharmacologi­
cally diverse but structurally similar peptides might interact 
with their specific targets in a analogous way despite the large 
differences in the amino acids sequence.
MATERIALS AND METHODS
Molecular Biology—The original DNA clone of the S/ia&er-related K 
channel (TSha l) from the central nervous system of rainbow trout 
(Onchorychus myki.ss) was kindly provided by Prof. Dr. G. Jeserich, 
University of Osnabrilck, Germany. In vitro site-directed mutagenesis 
of TShal was performed following standard procedures (18, 19) and 
according to manufacturer protocols when commercial kits were used. 
The vector used throughout this study was pSGEM (3118 bp), a modi­
fied version of pGEMHE, which was a generous gift of Prof. Dr. Michael 
Hollmann (Bochum University, Bochum, Germany).
Electrophysiological Recordings and Data Analysis—The two-elec­
trode voltage clamp technique in the Xenopus oocyte heterologous ex­
pression system was used to investigate the affinities of the toxin 
mutants for the different channel mutants. Oocyte injection and main­
tenance was performed as already described (20). The WT and mutant 
analogs of kM-RIIIK were synthesized, folded, and tested as already 
described (3, 4). The IC50 values for the block of TShal channels were 
calculated from the peak currents a t a test potential of 0 mV according 
to IC50 = fc/(\ -  fcj x  [Tx\, where fc is the fractional current, and [Tx\ 
is the toxin concentration. Data are given as the mean ± S.D. The 
calculation of the interaction free energy (AAG) from the electrophysi­
ological data were performed as described earlier (20).
Docking Calculations—The model of the TShal channel was ob­
tained by homology to the crystal structure of the KcsA channel (14) 
with a procedure similar to that described by Eriksson and Roux (7) to 
obtain the Shaker channel model. A large number of spatial restraints, 
extracted from the KcsA PDB file (1BL8), were optimized using the 
program MODELLER Version 6.2 to generate similarity-based models 
of TShal (21). The ideal 4-fold symmetry of the tetrameric channel was 
imposed on all the models. Of the 100 generated models, the one with 
the lowest MODELLER restraint energy was kept and refined by en­
ergy minimization with the program CNS solve 1.1 (22) using the 
“proteinallhdg* forcefield.
The docking protocol was based on a similar procedure as that used 
by Eriksson and Roux (7). 875 docking models of the complex between 
the TShal channel model structure and the NMR structure of KM- 
conotoxin RIIIK were generated with the program CNS solve 1.1 (22) 
and using mutant cycle derived intermolecular distance restraints. In 
the thermodynamic double mutant cycle analysis, two interacting mol­
ecules A and B are mutated at specific sites a and b to give two 
molecules A* and B*. The binding free energies AG for the wild type and 
single and double mutant complexes A-B, A*-B, A-B*, and A*-B* are 
combined to obtain the interaction free energy, AAGim = [AG(A*-B*) -  
AG(A*-B)J -  [AG(A-B*) -  AG(A-B)J. The AAGin is a measure of the
non-additivity of the mutations a* on A and b* on B and reveals a direct 
interaction of the sites a and b (23, 24). In these studies the AAG values 
of Fig. 3 were translated into intermolecular distances as follows: (a) 2 
kJ/mol < AAG £  3 kJ/mol corresponds to a very weak intermolecular 
distance (d) restraint between sites a. and b (4 A < d < 6 A); (b) 3 
kJ/mol < AAG £  4 kJ/mol corresponds to a weak intermolecular dis­
tance restraint (3.5 A < d < 5.5 A); (c) 4 kJ/mol < AAG £  5.5 kJ/mol 
corresponds to a medium distance restraint (2.5 A < d < 4.5 A); AAG >
5.5 kJ/mol corresponds to a strong distance restraint (1.5 A < d < 3.5 
A). If a. and b are polar or charged residues, the minimum distance 
between the heavy atoms of the polar or charged groups has to fulfill the 
intermolecular distance restraint; for non-polar residue pairs the min­
imum distance between all heavy atoms of the side chains is used. 
Because of the 4-fold symmetry of the TSha. 1 channel we used ambig­
uous distance restraints; the distance d,-j between a residue of the toxin 
O') and a residue of the channel (/') is described as, d,-j = Min(j|)-, -  /jAj|, 
il O O l  il 0  O l, il O o ”ll)> wI'ere A, B, C, and D are the four 
identical subunits of TSha. 1.
To avoid redundant identical complexes, all distances from the res­
idue Arg-10 of kM-RIIIK were assigned to the subunit A of the channel. 
The NMR structure of KM-conotoxin RIIIK shows that Arg-10 and 
Lys-18 are on opposite sides of the peptide; to ensure that the toxin is 
stretched over the pore, we impose that Lys-18 is close to the extracel­
lular loop of the channel unit opposite to that in contact with Arg-10 
(unit C). A total of 16 distance restraints were used: three very weak 
(Val-376-Leu-l, Met-375-Hyp-15, Glu-348-Arg-19), three weak 
(Glu-348-Leu-l, Met-375-Leu-l, Glu-348-Arg-10, five medium (Glu- 
354-Leu-l, Pro-349-Leu-l, Glu-348-Lys-18, Glu-354-Arg-19, Ser- 
351-Arg-19), and five strong (Glu-354-Arg-10, Pro-349-Arg-10, 
Ser-351-Arg-10, Glu-354-Lys-18, Pro-349-Arg-19). An additional dis­
tance restraint was added between the N terminus NH;! of the toxin 
and any electronic acceptor of the channel, following the dramatic 
decrease in the toxin affinity upon acetylation of the terminal amine (3). 
All distances were restrained with a harmonic potential.
The docking protocol consisted of a series of short torsion angle 
Molecular Dynamics trajectories. In the first step of the simulated 
annealing protocol the temperature was increased to 1000 K (500 steps 
of 10 fs for a total of 5 ps); during this phase the van der Waals radius 
of the atoms was decreased from 1 to 0.1. In the second step the 
temperature was slowly lowered to 300 K (1000 steps of 15 fs for a total 
of 15 ps), and the van der Waals radius was increased from 0.1 to 1. At 
the beginning of the trajectories, the toxin was positioned randomly at 
a distance of 15 A from the channel. All docking trajectories were 
started with different initial conditions by changing the initial veloci­
ties and the initial orientation of the toxin with respect to the channel 
pore axis. During the simulated annealing the electrostatic energy was 
turned on toward the end of the dynamics. A continuum solvent model 
was used with a dielectric constant € = 12 (7). The distance restraint 
force was fixed to 300 kcal mol~'A~2 during the dynamics.
Flexibility was allowed for the conformation of the toxin backbone of 
the amino acids 1-3 and of all the toxin side chains. The N terminus 
backbone of the peptide was allowed to change conformation with 
respect to the NMR structure following the observation that this region 
is h ighly flexible in solution (3). The peptide backbone of residues 4-24 
was restrained with an harmonic potential based on the root mean 
square deviation from the NMR structure with a force of 500 kcal 
mol~'A~2. This allows rotation and translation of the toxin with respect 
to the channel while keeping the overall folding close to that experi­
mentally determined. The conformation of the trans-membrane helices 
of the channel was kept fixed, the backbone of residues 336-386 was 
restrained to that of the initial model with an harmonic potential and a 
force of 300 kcal mol~'A~2, whereas the side chains of residues 336-386 
were allowed full flexibility.
The MD were followed by 6 cycles of 500 steps of energy minimiza­
tions where the backbone restraint function was turned off and the 
distance restraints were decreased to 75 kcal mol~'A~2. During the 
minimization the electrostatic potential was turned on.
The trajectories were analyzed using the g_cluster module of the 
GROMACS 3.1 program (25, 26). The clusters were generated using 
distances r.m.s.d. with the GROMOS method (27) and a cutoff of 0.2 nm. 
The r.m.s.d. used to define the clusters is an intermolecular r.m.s.d. 
containing distances between toxin residues Leu-1, Ser-6, Arg-10, Hyp-
13, Hyp-15, Lys-18, and Arg-19 and amino acids Glu-348, Pro-349, 
Glu-354, Gly-371, and Val-376 of the turret and pore helix region of the 


























Fig. 1. S e lec ted  s ite -d ire c te d  m u ta ­
t io n s  o n  th e  p o re  re g io n  o f T S h a l  K + 
c h a n n e ls . A, the amino acid alignment of 
the pore region of the Shaker and TSha 1 
K* channels (S5-S6 linker,) and the cor­
responding region of KcsA bacterial K* 
channel (M1-M2). B, whole-cell currents 
recorded from oocytes expressing TShal 
mutant channels before and after addi­
tion of the kM-RIIIK WT are shown. No­
tice the apparent slowing of activation of 
the currents in the presence of toxin illus­
trating the re-equilibrium of toxin bind­
ing to the open state (4). The dashed lines 
correspond to zero current.
RESULTS AND DISCUSSION 
We have performed a mutant cycling analysis to identify 
which amino acids of kM-RIIIK interact with specific residues 
in the vestibule of the ion channel pore of TShal. For this 
purpose we have generated several mutants of TShal with 
single amino acids changes in the pore region of the channel, 
where kM-RIIIK is likely to interact (4). Fig. 1A shows the 
alignment of the amino acid sequences of the pore region of 
TShal and Shaker together with the one of KcsA, for which a 
high resolution structure is available (14). Several mutations 
within this area have been constructed and functionally as­
sayed using the Xenopus expression system and two-electrode 
voltage-clamp experiments. The addition of 1 /um of kM-RIIIK  
leads to different reductions of the measured currents at a test 
potential of 0 mV for wild type and mutated ion channels (Fig. 
IB), demonstrating that the affinity of the peptide for the 
mutated channels is reduced. For M375K channels, hardly any 
block can be observed at this toxin concentration. This indi­
cates a very low affinity of the toxin for the mutated channel, 
which was estimated to be about 10 /um (kT) =  76 iim for the wild 
type channel). The changes in the affinity for the different 
channel mutants are summarized in Table I and confirm that 
kM-RIIIK indeed interacts with the pore region of the channel. 
The relative changes induced by the different mutations are 
summarized in Fig. 2. The mutations E348S, P349K, S351K, 
M375L, and V376T led to a 2-fold reduction in the affinity of
Table I
ICS0 Values for TShal mutant K block of kM-RIIIK WT 
The IC50 values are given by mean values ± S.E. NF, not functional; 
LE, low expression.
kM-RIIIK TCr,fl (0 mV)
nM n
WT 76 ± 10 9
E348S 110 ± 30 4
E348K 50 ± 10 3
P349K 130 ± 20 3
S351K 160 ± 10 4
E354K 490 ± 110 3
E354Q 270 ± 30 4
S366T NF
M375K 10730 ± 2460 3
M375L 140 ± 40 3
M375I 1360 ± 70 5





kM-RIIIK. Interestingly the mutation E348K did not have a 
significant effect despite the drastic change in the electrostatic 
properties of the side chain. The mutations E354K and E354Q 
resulted in a decrease of the affinity of 6- and 4-fold, respec­


























Fig. 2. In f lu en c e  o f  s in g le  p o in t  m u ta t io n s  in  th e  p o re  re g io n  
o f  T S h a l  o n  kM -R IIIK  b in d in g . The bar diagram shows the affinity 
of kM-RIIIK to the individual channel mutants normalized to wild type 
IC50. Asterisks represent a non-significant mean value compared with 
WT (unpaired t test).
ity change than M375L (12- versus 2-fold), whereas the most 
dramatic effect was observed for M375K (>100-fold).
To investigate which amino acids of the TShal channel pore 
interact with specific amino acids of kM-RIIIK, we measured 
the affinity of several toxin mutants to different ion channel 
mutants. In this analysis we concentrated on the amino acid 
residues of the toxin that had been shown to be functionally 
relevant (Leu-1, Arg-10; Lys-18, Arg-19) (3). The IC60 values for 
the different combinations of channel and toxin mutations are 
summarized in Table II, whereas Fig. 3 shows the correspond­
ing changes in binding energy (AAG) values. Assuming that a 
AAG value of 2 kJ/mol indicates that the distance between the 
two mutated residues is less than 6 A  (24), the data of Fig. 3 
indicate a quite complex network of interactions between the 
toxin and amino acids from different domains of the ion chan­
nel target.
In our previous work (3) we proposed a new pharmacophore 
model for the kM-RIIIK-TSha 1 complex based on the fact that 
the toxin lacks the dyad motif composed of a lysine and a 
hydrophobic amino acid residue and on the observation that all 
the functionally relevant residues are clustered on one surface 
of the peptide delimited by a ring of positive charges. In our 
model the ring of positive charges is used as an anchor to 
residues of the K h channel loops, and kM-RIIIK blocks the 
channel by covering the pore as a lid. Additionally, no posi­
tively charged side chain penetrates the channel pore. The new 
pharmacophore is fully supported by the mutant cycling anal­
ysis data. Arg-10, Lys-18, and Arg-19 have the largest interac­
tions with residues Glu-348, Pro-349, Ser-351, and Glu-354 of 
the turret and pore helix regions of the K h channel, thus 
excluding that any of the positively charged side chains pene­
trates the channel pore. Instead, the positively charged resi­
dues interact with the loops of the four channel units, anchor­
ing the peptide to the channel.
The mutant cycling data have been used as intermolecular 
distance restraints in docking calculations with the aim of 
obtaining a model for the complex of kM-RIIIK with the TShal 
channel. The structure of KM-conotoxin RIIIK, determined in 
aqueous solution by NMR, was docked to the model structure of 
the TShal channel using the distance restraints derived from 
the mutant cycle analysis, as described under “Materials and 
Methods.” According to what observed by Eriksson and Roux 
(7) for the Ag2Tx-Shaker complex, we find that one or two 
distance restraints are insufficient to achieve a selection 
among the different orientations of the toxin with respect to the 
channel pore. Therefore, we chose to use all the available 
distance restraints in the docking calculations. The 875 gener­
ated models can be subdivided into 4 clusters, which have been 
numbered from I to IV  according to increasing total energy 
(Fig. 4). Details on the criterion used for clustering are given 
under “Materials and Methods.” 90% of the generated models
belong to cluster I, which also contains the structure with the 
lowest energy; 6% of the models belong to cluster II, 3% to 
cluster III , and 1% to cluster IV. No intermolecular distance 
restraint violations are found in clusters I  and II, whereas all 
structures of clusters I I I  and IV  violate the distance restraints 
Glu-354 ^ Arg-19 and Met-375^Leu-l, respectively. The back­
bone conformation of the toxin is well defined in all four clus­
ters (toxin backbone r.m.s.d. are 1 , 1.4, 1 .1 , and 1 A  in clusters
I, II, I I I ,  and IV, respectively ). The conformation of the toxin 
backbone is quite close to the one determined by NMR in 
cluster I  (r.m.s.d. of 1.4 A ) ,  whereas it deviates the most in 
clusters I I I  (r.m.s.d. of 2.5 A ) .  The toxin conformations of clus­
ters I I  and IV  have r.m.s.d. values to the NMR-determined 
conformation of 1.8 and 1.6 A ,  respectively. The details of the 
atomic interactions for the lowest energy structure of each 
cluster are given in the following section.
The Four Models
Cluster I—The positively charged side chain of Arg-10 of 
kM-RIIIK is located in a negatively charged pocket of the 
extracellular loop of unit A of the TSha 1 channel defined by the 
carbonyls of Pro-349, Glu-350, and Ser-351 and by the side 
chains of Glu-348, Ser-351, and Glu-354 (Fig. 5). The strong 
interaction of Arg-10 with Glu-354 accounts for the decreased 
affinity of kM-RIIIK to the Shaker channel, where the homol­
ogous position to Glu-354 is occupied by a lysine. The positively 
charged side chain of Lys-18 is surrounded by the backbone 
carbonyls of Pro-349, Glu-350, and Ser-351 and the side chains 
of Glu-348, Ser-351, and Glu-354 of unit C, whereas the Arg-19 
interacts with the negatively charged side chain of Glu-354 and 
with the backbone carbonyl of Ser-351 of unit C (Fig. 5). The 
electrostatic interactions of Arg-10, Lys-18, and Arg-19 anchor 
the peptide to the channel loops, stretching it over the channel 
pore. The interactions of Leu-1 with the channel unit B are 
both electrostatic and hydrophobic (Fig. 5). The positively 
charged N terminus is situated among the backbone carbonyl 
of Glu-348 and the side chains of Gln-352 and Glu-354, justi­
fying the consistent decrease in affinity for the JV-acetylated 
toxin (3); the hydrophobic side chain packs against the side 
chains of Glu-350 and Gln-352 and contacts the methyl groups 
of Met-375 and Val-376.
Cluster 11—The positively charged side chain of Arg-10 con­
tacts the backbone carbonyls of Pro-349, Glu-350, and Ser-351 
and the side chains of Glu-348 and Glu-354 of unit A, similarly 
to cluster I. Lys-18 interacts with the backbone carbonyls of 
Pro-349, Glu-350, and Ser-351 and with the side chains of 
Glu-348, Ser-351, and Glu-354 of unit C; Arg-19 contacts the 
side-chain carbonyls Glu-354 of the same unit C. As for cluster
I, the electrostatic interactions of the side chains of Arg-10, 
Lys-18, and Arg-19 with loop residues of unit A and C stretch 
the peptide over the channel pore. In cluster II, Leu-1 is situ­
ated close to the loop residues of unit D, unlike in cluster I, 
where Leu-1 contacts the extracellular loop of unit B (Fig. 4). 
The positively charged N terminal group contacts the side 
chains of Gln-352 and Glu-354, whereas the Leu side chain has 
hydrophobic contacts with Pro-349. The distance between the 
side chain of Leu-1 and the side chains Met-375 and Val-376 in 
this model is higher than in model I.
Cluster 111—As in the clusters I and II, the positively charged 
side chain of Arg-10 interacts with the backbone carbonyls of 
Pro-349, Glu-350, and Ser-351 and with the side chain carbonyl 
of Glu-354 of unit A. The amino group of Lys-18 is situated in 
a pocket formed by the backbone carbonyls of Pro-349, Glu-350, 
and Ser-351 and by the side chain of Glu-354 of unit C, whereas 
Arg-19 contacts the backbone carbonyls of Pro-349 and Glu-350 
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Table II
IC50 values for TShal mutant K + block o f kM-RIIIK  WT and analogs 
The IC50 values (in nM) are given by mean values ± S.E. n = number of independent experiments. ND, not done; NB, no block. AcLl, 
acetyl-Leu-1.
kM-RIIIK analog IC50 values (mean ± S.E.) (n)
WT LIA LIT AcLl LIM R10 A K18A R19A K18R/R19K
WT 76 ± 10 (9) 3,180 ± 120 (6) 1,380 ± 450 (5) 7,620 ± 380 (5)
JIM
340 ± 50 (5) 4,220 ± 330 (7) 3,900 ± 530 (6) 1,530 ± 240 (9) 180 ± 40 (7)
E348S 110 ± 30 (4) 1,920 ± 290 (4) 480 ± 120 (3) ND ND 1,220 ± 280 (3) 600 ± 100 (3) 820 ± 210 (4) 100 ± 10 (3)
E348K 50 ± 10(3) 440 ± 110 (3) 540 ± 100 (4) ND ND 770 ± 100 (4) 720 ± 50 (4) 460 ± 60 (4) 150 ± 10 (3)
P349K 130 ± 20 (3) 1,740 ± 110 (3) 280 ± 20 (5) ND ND 680 ± 100 (3) 3,390 ± 100 (3) 200 ± 30 (3) 140 ± 10 (4)
S351K 160 ± 10 (4) 2,960 ± 310 (4) 1,700 ± 390 (4) ND ND 810 ± 40 (3) 1,390 ± 350 (3) 770 ± 80 (4) 260 ± 60 (3)
E354K 490 ± 110 (3) 14,070 ± 4,740 (3) 1,310 ± 100 (3) ND ND 1,640 ± 300 (3) 2,070 ± 220 (3) 740 ± 140 (3) 620 ± 80 (3)
E354Q 270 ± 20 (6) 1,660 ± 80 (5) 1,400 ± 200 (5) ND ND 1,700 ± 340 (4) 1,870 ± 350 (4) 1,550 ± 110 (5) 490 ± 30 (4)
M375K 10,730 ± 2,460 (3) NB NB NB NB NB NB NB NB
M375I 1,360 ± 70 (5) 11,400 ± 1,030 (3) 4,740 ± 580 (4) 26,610 ± 2,860 (3) 1,360 ± 10 (3) 37,400 ± 7,260 (3) 35,160 ± 7,330 (3) 5,910 ± 790 (4) 1,420 ± 150 (3)
M375L 140 ± 40 (3) 3,260 ± 460 (4) 690 ± 40 (3) 11,400 ± 4,060 (3) 470 ± 50 (3) ND ND ND ND







Fig. 3. S u m m ary  o f  m u ta n t  cycle  
a n a ly s is . Coupling energy (AAG ± S.E.) 
between TShal mutants and analogs of 
kM-RIIIK representing important resi­
dues for binding (Leu-1, Arg-10, Lys-18, 
and Arg-19). AAG values exceeding 2.0 
kJ/mol indicate coupling interactions 
within 6 A distance. LIA mutant (empty 
bars), L1I {gray-filled bars), R10A (net- 
filled bars), K18A (diagonal-stripped 
bars), R19A (horizontal-stripped bars) 
and K18R/R19K (mosaic-filled bars). All 
numbers represent the means of 3-6  in­
dependent determinations. AAG are 
taken as absolute values.
the negatively charged side chain of Glu-354 and the positively 
charged side chain of Arg-19 is larger than in cluster I  and II. 
The positive charge of the arginine side chain is surrounded by 
several backbone carbonyls and a serine side chain of the toxin 
itself. Leu-1 is situated close to the extracellular loop of unit D. 
The positively charged N terminus weakly interacts with the 
backbone carbonyl of Glu-354; the hydrophobic leucine side 
chain packs against Pro-349 and Ser-351, whereas the distance 
to Met-375 and Val-376 is larger than in cluster I.
Cluster IV—The backbone carbonyls of Pro-349 and Glu-350 
and the side chain of Glu-354 of unit A interact with Arg-10 as 
in all other models. The side chains of Glu-348, Gln-352, and 
Glu-354 of unit C surround Lys-18, whereas Arg-19 stretches 
over toward the backbone carbonyls of Glu-348 and Pro-349 
and the side chains of Glu-348 and Glu-354 of unit D. The 
positively charged N terminus of Leu-1 interacts with the side 
chain of Glu-354 of unit D, whereas the Leu side chain only 
contacts the side chain of Gln-352 and is further from Met-375 
than in any other cluster.
In all four clusters the positively charged side chain of Arg-10
is situated in a negatively charged pocket of unit A, defined by 
the backbone carbonyl of the stretch 348^351 and by the side 
chain carbonyls of Glu-348 and Glu-354. This reflects the high 
AAG values observed upon introduction of a positive charge in 
position 349, 351, and 354 and explains the higher affinity of the 
toxin for the TShal channel as opposed to the Shaker channel, 
where a lysine is found in the homologous position to Glu-354. 
The atomic interactions of Lys-18 with loop residues 348^354 are 
very similar to those of Arg-10. Thus, the two positively charged 
side chains of Arg-10 and Lys-18 serve as anchors to very similar 
negatively charged pockets of the channel extracellular loops and 
pore helix. An additional anchor is represented by Arg-19 that 
tightly interacts with the side chain of Glu-354. However, Arg-19 
can interact either with the same unit as Lys-18 (unit C), as in 
clusters I and II, or with the neighboring unit, as in clusters I II  
and IV, depending on the conformation of the Arg-19 side chain. 
This heterogeneity is observed also for structures belonging to 
the same cluster (1% of the structures of cluster I and 20% of the 
structures of cluster II). The mutant cycling data and conse­

























Fig. 4. T h e  fo u r  m o d e ls  fo r  th e  co m p lex  KM -conotoxin RIIIK- 
T S h a l  K + c h a n n e l. The backbone of the toxin is represented in blue 
(cluster I), green (cluster II). yellow (cluster III), and magenta (cluster 
IV). The toxin deeply interacts with only three units of the channel. In 
cluster I. units A, B. and C are involved in electrostatic and hydrophobic 
contacts with toxin side chains; in clusters 11, 111, and IV. units A, C. 
and D contact the toxin side chains.
imity to the side chain of Pro-349 than Lys-18 (AAG = 6.31 k j  
mol-1  for the R19A/P349K mutation and 1.67 k j  mol-1  for the 
K18A/P349K mutation).
More complex are the interactions of Leu-1. Mutant cycling 
data point to the existence of contacts between Leu-1 and 
Glu-348, Pro-349, Glu-354, Met-375, and Val-376. The distance 
restraints with Pro-349 and Glu-354 are classified as medium 
and are reflected in electrostatic contacts of the positively 
charged N terminus of Leu-1 with the side chain carbonyl of 
Glu-354. The hydrophobic contacts of Leu-1 are different in the 
four models; the weak distance restraints with Met-375 and 
Val-376 are best satisfied in clusters I  and II, where Leu-1 
reaches Met-375 and Val-376 the closest.
Overall Orientation o f the Toxin with Respect 
to the Channel
Given its small size, kM -RIIIK  cannot interact with the 
extracellular loops of all four units. In all four clusters the toxin 
contacts three of four units of the K+ channel. In model I, units 
A, B, and C bind the toxin, whereas in models II, III , and IV  
units A, C, and D are involved in contacts with the peptide (Fig. 
4). According to the NMR studies (3), the toxin has a discoid 
shape; in model I  the flat surface of the disc is out of the plane 
defined by the four channel loops, whereas in models II, I II , and 
IV  the toxin is flattened on the channel like a pancake. Al­
though the toxin contacts only three of the four units, the 
accessibility for a potassium ion to the selectivity filter of the 
channel is reduced by more than 85% in all models.
Does One o f the Four Models Better Fit 
the Mutational Data?
To discriminate between the four models, we analyzed the 
location of the functionally relevant residues of the toxin with 
respect to the channel pore (Fig. 6). In our previously published 
mutational analysis (3), we identified Leu-1, Arg-10, Lys-18, 
and Arg-19 as being fundamental for binding to the K+ channel 
(red in Fig. 6); Ser-3, Asn-8, Leu-11, Hyp-13, Val-14, Hyp-15, 
and Asn-20 resulted to be of medium importance (yellow in Fig. 
6), whereas mutations of Hyp-2, Ser-6, Leu-7, Leu-9, Hyp-21, 
and Thr-24 to alanine did not significantly reduce the activity 
of the toxin (gray in Fig. 6). Model I is in very good accord with 
the mutational data (Fig. 6A). All the functionally relevant 
residues with the exception of Asn-8 face the channel pore or
are in contact with the loops, whereas no residue that resulted 
in being unessential for function strongly interacts with the 
channel. The only gray residue facing the channel pore is 
Ala-16, for which no mutational data are available. Model I I  
fits the mutational data worse than model I. Three residues of 
medium importance for binding (Ser-3, Asn-8, and Leu-11) are 
not in contact with the channel, whereas the C terminus of the 
toxin, whose side chain was found to be irrelevant for binding, 
contacts the loop of unit C (Fig. 6B). In model I I I  the residues 
21^24 at the C terminus of the toxin are involved in several 
contacts with units C and D, whereas the stretch 11-15, which 
contains several residues of medium importance for function, 
points toward solution (Fig. 6 0 . In model IV, the C terminus of 
the toxin deeply penetrates the channel, and a great portion of 
the residues that are unimportant for binding interacts with 
the protein (Fig. 6D).
The fact that a whole stretch of functionally relevant toxin 
residues (residues 11-15) is not in contact with the channel in 
model III, and IV  cannot be taken as the sole argument to 
exclude these models, as mutations at this site might destabi­
lize the overall structure of the toxin. However, it is rather 
improbable that amino acids profoundly interacting with the 
protein (stretch 21^24) can be mutated to alanine without 
influencing affinity. All in all the mutational analysis data are 
severely contradicted by models I I I  and IV, allowing us to 
exclude them as valid representations of the complex between 
kM-RIIIK and the TSha 1 channel. Model I I  is retained at this 
stage, as it does not contradict the mutational data as exten­
sively as model I I I  and IV.
Interaction o f kM-RIIIK  with the TShal Pore
To further discriminate between cluster I  and II, we ana­
lyzed which part of the toxin is in close proximity to the selec­
tivity filter. For different toxins that interact with voltage- 
gated K+ channels there is evidence that a positively charged 
side chain occludes the channel pore (6- 8). This positively 
charged amino acid is part of the functional dyad together with 
an amino acid containing a hydrophobic side chain, usually a 
tyrosine. In our previous work we demonstrated that KM-cono­
toxin R IIIK  does not possess a functional dyad. Moreover, as a 
result of the mutant cycling analysis, all positively charged 
amino acids interact with the turret or pore helix regions of the 
channel and, therefore, cannot penetrate the channel pore. 
Which toxin residues then face the channel pore in our models? 
In model I the Hyp-15 is very close to the selectivity filter of 
units C and B, and the hydroxyl oxygen at the Cy is at a 
hydrogen bond distance (2.8 A) from the carbonyl of the Gly- 
373 of the selectivity filter of unit B (Fig. 7A). In model I I  the 
Hyp-13 is in proximity of the selectivity filters of unit A and D 
but makes no tight direct contact with them (Fig. IB). To 
distinguish between the two models, mutant cycle data involv­
ing the residues of the GYG selectivity filter would be required. 
This is unfortunately not feasible as any mutation of residues 
in the selectivity filter destroys the channel activity. Neverthe­
less, model I and model I I  can be distinguished by considering 
the distance of Hyp-13 or Hyp-15 from the amino acid Val-376 
of the TShal channel. In model I Hyp-15 is expected to be 
closer to Val-376 (of unit C) than Hyp-13, while in model I I  both 
Hyp-13 and Hyp-15 are at a similar distance from Val-376 of 
units D and C, respectively. The mutant cycle analysis per­
formed using TSha I V376T resulted in a AAG of 0.6 k j  mol- 1 
for 013A and of 2.51 k j  m o r1 for 015A, which reflects the 
geometry of model I much better than that of model II. To 
obtain further evidence for the interaction of Hyp-15 with the 
amino acids of the selectivity filter, we assayed the affinity of 
the 015R and 015K mutants, following the idea that a positive 
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F ig. 5. S te re o  p ic tu re  o f  m o d e l I 
sh o w in g  th e  d e ta i ls  o f th e  e le c tro ­
s ta tic  a n d  h y d ro p h o b ic  in te ra c t io n s  
o f th e  to x in  w ith  th e  c h a n n e l. The
amino acids Glu-348, Ser-351, and Glu- 
354 of unit A (in magenta) are in deep 
contact with the amino acid Arg-10 of the 
toxin; the same amino acids Glu-348, Ser- 
351, and Glu-354 of unit C (in yelloio) 
contact the side chains Lys-18 and Arg-19 
of the toxin, whereas amino acids Glu- 
350, Gln-352, Met-375, and Val-376 of 
unit B (ingreen) interact with the charged 
N terminus and with the hydrophobic 









not be easily accommodated in proximity of the tight channel 
pore. The affinity of the mutant 015K for the wild type TShal 
channel was found to be 430 ± 20 nM (n = 4) against a value of 
930 ± 160 dm (/i = 3) for the mutant 015A. This indicates that 
a positive charge in position 15 is preferred to the absence of 
any polar group, as would be expected if the side chain of 
Hyp-15 interacts with the carbonyls of the selectivity filter. On 
the other hand 015R binds the channel with a kD of 2940 ± 540 
dm in = 4), suggesting that Hyp-15 is situated close to the 
channel pore, where there is no space to accommodate the 
bulky arginine side chain. Although these data do not prove 
directly the interaction of Hyp-15 with residues of the selectiv­
ity filter, they strongly support it.
The Best Model
Model I provides a novel pharmacophore for the interaction 
of toxin peptides with K h channels that best explains the 
mutational and mutant cycle data for the kM-RIIIK-TShal 
complex. The peptide is anchored to the extracellular loops of 
three of the four channel units via a basic ring provided by the 
side chain of Arg-10, Lys-18, Arg-19, and the protonated N 
terminus of Leu-1, and no positively charged residue occludes 
the channel pore.
Unlike several other peptides that target voltage-activated 
K h channels, including charybdotoxin from a scorpion, BgK 
from a sea anemone, and dendrotoxin from snakes, KM-cono- 
toxin R IIIK  does not contain a functional dyad of a hydrophobic 
and a positively charged side chain, which was proposed to be 
the minimal functional core for K h channel-blocking peptides 
(9-12). The dyad model has been recently challenged by Mou- 
hat et al. (13), who demonstrated by mutational analysis and 
docking calculations that a functional dyad is not strictly re­
quired for binding of the scorpion toxin P il to the voltage-gated 
Kvl.2 potassium channel. Instead, a basic ring of four posi­
tively charged side chains was proposed to be a fundamental 
recognition element by the residue Asp-355 of each of the four 
Kvl.2 a-subunits. Similarly, we find that four positively 
charged residues of KM-conotoxin R IIIK  are involved in elec­
trostatic interactions with loop and pore helix amino acids of 
three subunits of the TShal channel. Residue Glu-354 of dif­
ferent units is involved in contacts with all four positively 
charged residues of the peptide. This amino acid distinguishes
the TShal channel, which is the highest affinity target of 
kM-RIIIK (IC60 = 76 ± 10 dm), from other channels of the same 
family, as for example the Shaker (IC60 = 1.2 pu) (4), where the 
homologous position is occupied by a lysine (Lys-427), and 
Kvl.2 (IC60 = 400 dm) (5), where the homologous position is 
occupied by a neutral proline (Pro-359). Our model suggests 
that Glu-354 is a fundamental recognition element for kM- 
R IIIK  binding to the TShal channel. However, the complete 
lack of affinity for kM-RIIIK shown by other members of the 
Kvl family (5), which like Kvl.2 contain an uncharged amino 
acid at position 359, indicates that channel amino acids other 
than Pro-359 play a comparably important role in toxin recog­
nition. For the toxin it is reasonable to hypothesize that the 
spatial distribution of the positive charges of the basic ring 
exerts a fundamental role in channel recognition and provides 
a solid framework for the high selectivity of the K h channel- 
blocking toxins among the diverse targets.
As shown in the NMR-derived solution structure of the pep­
tide (3), the basic ring defined by Leu-1, Arg-10, Lys-18, and 
Arg-19 separates the peptide in two faces; all functionally rel­
evant residues, identified by systematic alanine mutations, 
cluster on one face, which is in contact with the channel in 
model I.
The mutant cycle analysis excludes that one of the positively 
charged side chains of kM -RIIIK  penetrates the channel pore, 
as they all interact with amino acids of the extracellular loop 
and pore helix. In model I  the C-y-hydroxyl of Hyp-15 tightly 
interacts with the carbonyl of Gly-373 of the unit C selectivity 
filter. It  has been proposed that the carbonyls of the selectivity 
filter exert an essential role in the coordination of K h ions at 
the entrance of the channel pore (14). Dehydration of the ions 
must occur at the selectivity filter, as a hydrated K h is too large 
to enter the channel pore. By acting as electron donors, the 
carbonyls of the selectivity filter replace the water molecules 
usually associated with K h ions in solution, thus compensating 
for the large energetic penalty of the dehydration process. A 
H-bond between the C-y-hydroxyl of Hyp-15 would block one of 
the selectivity filter carbonyls, seriously disturbing the ener­
getic of the K h dehydration process.
A thorough analysis of the binding mode of various scorpion 
toxins to diverse K h channels (28, 29) revealed three possible 
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Fig. 6. F i l l in g  sp a c e  r e p r e s e n ta t io n  o f  K M -conotox in  R IIIK  in  th e  f o u r  c lu s te r s  ( c lu s te r s  I-IV  in  p a n e l s  A -D ), sh o w in g  th e  
m u ta t io n a l  d a ta  o b ta in e d  by  sy s te m a tic  a la n in e  s u b s t i tu t io n  (3) in  c o lo r  c o d e . The functionally most relevant residues are 
represented in red (Leu-1, Arg-10, Lys-18 and Arg-19); the residues of medium importance for binding (Ser-3, Asn-8, Leu-11, Hyp-13, Val-14, 
Hyp-15, and Asn-20) are shown in yellow, whereas the residues that are irrelevant for binding (Hyp-2, Ser-6, Leu-7, Leu-9, Hyp-21, and 



























F ig. 7. I n te ra c t io n s  o f  th e  re s id u e s  H yp-13 a n d  Hyp-15 o f K M -conotoxin R IIIK  w ith  th e  se le c tiv ity  f i l te r  o f  th e  c h a n n e l. In the two
panels A  and B  models 1 and 11 are shown, respectively. The two representations differ for a rotation of about 180° around the channel axis to allow 
for a better visualization of Hyp-15 in the two models. A, model 1. the Cy-OH group of Hyp-15 is close to the selectivity filter of unit B and C and 
in H-bond distance from the carbonyl oxygen of Gly-373 of unit C. B, model 11. both Hyp-13 and 015 are close (<5 A) to the selectivity filter of unit 
C and D. but no specific interaction can be identified.
ilar toxins; they are the internal binding mode, where residues 
of the turret region, pore helix, and selectivity filter of the 
channel are involved, the intermediate mode, involving resi­
dues of the turret region, and the external mode, which in­
volves residues far away from the selectivity filter. In the 
intermediate and external binding mode no functional dyad is 
observed on the peptide site. This analysis, triggered by the 
observation that the scorpion toxin BmTx3 can block both 
A-type K h and HERG currents (30) using different functional 
faces, confirms the existence of different binding modes of 
peptidic toxins to K h channels, some of which do not involve a 
direct obstruction of the pore by a positively charged side chain. 
Based on the solution structure and the mutational analysis of 
kM-RIIIK, we proposed that this toxin could bind the TShal 
channel in the intermediate mode. However, the mutant cycle 
data and the docking model I  prove the interaction of toxin 
residues with amino acids in the turret and pore helix regions 
and to some extent also with the selectivity filter. In the clas­
sification of Rodriguez de la Vega et al. ( 28), the position of the 
toxin in the kM-RIIIK-TS/mJ channel complex resembles the 
internal binding mode best. However, the side chain of Hyp-15 
does not completely occlude the channel pore as the lysine of 
the functional dyad but rather disturbs the charge distribution 
at the selectivity filter by involving one of the carbonyls in 
a H-bond.
Despite the entirely different pharmacological specificity and 
many differences in the amino acid sequence, KM-conotoxin 
R IIIK  shows striking structural similarities to ju-conotoxin 
G IIIA  (31-33), which specifically blocks NaV1.4 Na h channels. 
KM-conotoxin R IIIK  and ju-conotoxin G IIIA  belong to the same 
phylogenetic family and share a common pattern of cysteine 
bridges. Interestingly, Hyp-15 of KM-conotoxin R IIIK  is at the 
homologous position of Arg-13, the Na h channel pore occluding 
residue in the peptide sequence of ju-conotoxin GIIIA. This fact 
together with the high structural similarity of the two toxins 
suggests that KM-conotoxin R IIIK  and ju-conotoxin GIIIA  
might block K h and N a h channels, respectively, with a similar 
geometry. However, because the 015R mutant of kM -RIIIK  is 
inactive on Nav1.4 sodium channels (data not shown), addi­
tional parameters must be involved in determining the selec­
tivity of the two peptides for Na h or K h channels. Similarly to 
kM-RIIIK, a ring of positively charged side chains can be iden­
tified on ju-GIIIA as well (3). Most likely the overall shape of the 
two peptides and the charge distribution of the basic ring are 
key determinants for the N a h or K h channel selectivity of 
ju-conotoxin G IIIA  and KM-conotoxin RIIIK.
Conclusions
We have presented a combined approach based on thermo­
dynamic mutant cycle data and docking calculations to derive 
the structure of the complex of KM-conotoxin R IIIK  with the K h 
channel TShal. This peptide shows a novel binding mode to the 
K h channel that is not centered around a functional dyad. 
Instead, a ring of positive charges anchors the peptide to the 
turret and pore helix region of the channel; the electrostatic 
complementarity between this ring and the channel side chains 
is likely to be responsible for the selectivity of kM-RIIIK toward 
the TShal channel, as it can be inferred from the important 
role of Glu-354 of different units in contacting the basic ring. 
This amino acid is not present in lower affinity targets of 
kM-RIIIK, such as the Shaker channel. The intermolecular 
interactions involving the channel loops and the toxin posi­
tively charged side chains can be of general importance in 
determining the selectivity of peptidic toxins for ion channels.
The role of the positive charged side chain that in many 
peptide-ion channel complexes occludes the channel pore is 
partially exerted by Hyp-15, whose side chain, however, is too 
short to penetrate the pore. The Cy-OH of Hyp-15 contacts the 
carbonyls of the selectivity filter of one to two units, perturbing 
the electrostatic forces that regulate the dehydration of potas­
sium ions at the pore entrance.
The binding mode of kM-RIIIK to the TShal channel closely 
resembles that of ju-conotoxin G IIIA  to the Nav1.4 N a h chan­
nel. The three-dimensional structure of the two peptides is 
highly similar in the C-terminal part despite the poor super­
position of the amino acid sequence. Hyp-15 of kM-RIIIK occu­
pies the homologous position of Arg-13 of ju-GIIIA, which is 
known to occlude the N a h channel pore. Both peptides contain 
a basic ring, although the form and the charge density at the 
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conotoxins have developed a similar scaffold and binding ge­
ometry to their respective targets, whereas the pharmacologi­
cal selectivity is determined by the exact charge distribution 
and three-dimensional shape.
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